Chemotherapy tolerance after radioimmunotherapy with 90Y-CC49 monoclonal antibody in patients with advanced non-small cell lung cancer: clinical effects and hematologic toxicity.
about
Chemotherapy tolerance after radioimmunotherapy with 90Y-CC49 monoclonal antibody in patients with advanced non-small cell lung cancer: clinical effects and hematologic toxicity.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Chemotherapy tolerance after r ...... ects and hematologic toxicity.
@ast
Chemotherapy tolerance after r ...... ects and hematologic toxicity.
@en
type
label
Chemotherapy tolerance after r ...... ects and hematologic toxicity.
@ast
Chemotherapy tolerance after r ...... ects and hematologic toxicity.
@en
prefLabel
Chemotherapy tolerance after r ...... ects and hematologic toxicity.
@ast
Chemotherapy tolerance after r ...... ects and hematologic toxicity.
@en
P2093
P1476
Chemotherapy tolerance after r ...... ects and hematologic toxicity.
@en
P2093
Albert F LoBuglio
Elizabeth M Busby
Francisco Robert
P304
P356
10.1089/108497803322285071
P577
2003-06-01T00:00:00Z